Corporate Profile Our Vision, Mission and Values Our Investment Criteria Board of Directors Advisory Panel Investment Professionals Corporate Professionals Biomedical Sciences Clean Technology Digital Media Other Key Industries 26 Jan 2010 CWT Announces EDBI as the New Investor Other Key Industries CWT Limited, a leading Singapore headquartered integrated logistics service provider with global operations, today announced the subscription of 16 million new ordinary shares by strategic investor, EDB Investments Pte Ltd (“EDBI”). 06 Jan 2010 Innovalight Raises an Additional $18 Million to Expand Silicon Ink Manufacturing Clean Technology Innovalight, Inc., a privately-held firm selling silicon ink-based high efficiency solar cell materials and technology, today announced that the company has raised $18 million in additional capital.This series D financing was led by EDB Investments (EDBI) of Singapore. 02 Dec 2009 S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety & Tolerability in P1 Studies. Biomedical Sciences S*BIO Novel Oral JAK2 inhibitor SB1518 demonstrates safety & tolerability in P1 studies for the treatment of Myeloproliferative & other hematological disorders 01 Dec 2009 Forma Therapeutics raises $25.5M Series B Biomedical Sciences Forma Therapeutics raises $25M Series B 27 Nov 2009 Eye on Mandarin Market Digital Media Xinya Media, a new home-grown cable content provider, has lined up plans to create programmes to reach 12 billion people. 26 Nov 2009 Xinya Media Completed Its Latest Round of Financing Digital Media Xinya Media (Xinya) today announced that EDB Investments (EDBI) has taken a stake in Xinya. Including the investments from Gobi Partners and Cheng’s Film, Xinya has successfully raised a total amount of US$9 million in this round. The new funds will aid the growth plan of Xinya and expand its market reach in Asia Pacific. 04 Nov 2009 MerLion Pharmaceuticals Pte Ltd receives IND Approval from the FDA for Finafloxacin. Biomedical Sciences MerLion Pharmaceuticals Pte Ltd receives IND approval from the FDA for Finafloxacin. 28 Oct 2009 ScanScout Completes $8.5 Million Series B Funding Round Digital Media ScanScout ( http://www.scanscout.com ) today announced that Singapore based EDB Investments (EDBI) has made an investment in ScanScout to close the in-stream video ad provider’s series B round at $8.5 million. 06 Oct 2009 Inviragen Merges with SingVax & Completes $15 million Series A Financing Biomedical Sciences Inviragen merges with SingVax and completes $15 million Series A financing. 25 Aug 2009 Fluidigm:250M Microfluidic Valves Manufactured Biomedical Sciences Fluidigm today announced that its Singapore biochip factory has manufactured and shipped more than 250M microscopic NanoFlex valves. 18 Aug 2009 Adamas Pharmaceuticals Raises $40M in Series D Financing Biomedical Sciences Adamas Pharmaceuticals has closed a $40M Series D round of funding led by Aeris Capital AG 18 Aug 2009 Adamas Pharmaceuticals signs crada with U.S Navy. Biomedical Sciences Adamas Pharmaceuticals signs crada with U.S Navy to conduct preclinical studies of triple-combination antiviral drug therapy for influenza A. 17 Jul 2009 Conformis raised US$50M from global investors Biomedical Sciences Conformis, a unique Medtech company with a customized approach to knee surgery replacement announced it has raised more than $50M from global investors..... 18 Mar 2009 S*BIO Pte Ltd Biomedical Sciences S*BIO Receives BioSingapore’s 2009 Award for the Most Successful Bio-Partnership in Asia 15 Mar 2009 Forma Therapeutics Biomedical Sciences FORMA Therapeutics and Experimental Therapeutics Centre of Singapore Collaborate to Develop Therapeutics Against a Broad Range of Novel Targets 06 Mar 2009 S*BIO Pte Ltd Biomedical Sciences S*BIO Receives BioSpectrum Editor's Choic, Emerging BioScience Company of Singapore Award 21 Jan 2009 S*BIO Pte Ltd Biomedical Sciences S*BIO and Tragara Announce an Exclusive Worldwide License Agreement for Novel Multi-kinase Inhibitor SB1317 06 Jan 2009 S*BIO Pte Ltd Biomedical Sciences S*BIO Announces Collaboration with Onyx for JAK2 Inhibitors in the North American & European Markets 06 Jan 2009 Forma Therapeutics Biomedical Sciences Forma Therapeutics Debuts with 25 Million in Funding - Will Focus on Difficult Cancer Targets 31 Dec 2008 Singapore Medical News Biomedical Sciences EDB reports an outstanding year of growth and quality investments in 2007 13 Nov 2008 Inotek Pharmaceuticals Corporation Biomedical Sciences Patents Issue for Inotek Pharmaceuticals' Lead Clinical Candidates in Glaucoma and Contrast-Induced Nephropathy 20 Oct 2008 S*BIO Pte Ltd Biomedical Sciences S*BIO Completes US$26 Million Equity Financing 18 Sep 2008 S*BIO Pte Ltd Biomedical Sciences S*BIO Initiates U.S. Phase I Clinical Trials of Oral JAK2 Inhibitor SB1518 for the Treatment of Hematological Malignancies 09 Sep 2008 ES Cell International Pte Ltd Biomedical Sciences ES Cell International Announces Partnership with Large Pharma for assessment of GMP-Grade Stem Cell Lines 09 Sep 2008 Dx Assays Pte Ltd Biomedical Sciences Singapore's first Commercial Developer of Molecular Diagnostic Assays commences operations 09 Sep 2008 ES Cell International Pte Ltd Biomedical Sciences Human Stem Cell help mice in MS Research 22 Jul 2008 Merlion Pharmaceuticals Pte Ltd Biomedical Sciences BRAIN expands its BioArchive by the acquisition of genetic resources for White Biotech screening from MerLion Pharmaceuticals GmbH 21 May 2008 U3 Pharma AG Biomedical Sciences Daiichi Sankyo Co Ltd. to buy U3 Pharma for US$234M (150M Euros) 28 Mar 2008 Alexza Pharmaceuticals, Inc. Biomedical Sciences Bio*One takes US$10m stake in Nasdaq firm 06 Dec 2007 Merlion Pharmaceuticals Pte Ltd Biomedical Sciences MerLion MerLion Pharmaceuticals Wins Prestigious Pharmaceutical Industry Scrip Award 03 Dec 2007 Dx Assays Pte Ltd Biomedical Sciences QIAGEN and Bio*One Capital Enter into Joint Venture to Develop Molecular Diagnostics Products

[Top | Home]

Contact Us | © 2008 EDBI. All rights reserved.